Editorial: Resistance to Endocrine Therapies in Cancer.
作者信息
Ranganathan Prathibha, Chakrabarty Anindita, Hiscox Stephen, Limaye Anil Mukund, Vella Veronica
机构信息
Centre for Human Genetics, Bengaluru, India.
Department of Life Sciences, Shiv Nadar University, Greater Noida, India.
出版信息
Front Endocrinol (Lausanne). 2020 Apr 9;11:196. doi: 10.3389/fendo.2020.00196. eCollection 2020.
Abstract
摘要
相似文献
1
Editorial: Resistance to Endocrine Therapies in Cancer.社论：癌症内分泌治疗的耐药性
Front Endocrinol (Lausanne). 2020 Apr 9;11:196. doi: 10.3389/fendo.2020.00196. eCollection 2020.
2
Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer?克服乳腺癌中的内分泌耐药性：信号转导抑制剂是答案吗？
Breast Cancer Res Treat. 2008 Apr;108(3):307-17. doi: 10.1007/s10549-007-9606-8. Epub 2007 May 22.
3
[Biomarkers of endocrine therapy-resistance in breast cancers].[乳腺癌内分泌治疗耐药的生物标志物]
Bull Cancer. 2010 Aug;97(8):951-63. doi: 10.1684/bdc.2010.1137.
4
Endocrine therapy in post-menopausal women with metastatic breast cancer: From literature and guidelines to clinical practice.绝经后转移性乳腺癌患者的内分泌治疗：从文献和指南到临床实践。
Crit Rev Oncol Hematol. 2016 Apr;100:57-68. doi: 10.1016/j.critrevonc.2016.02.008. Epub 2016 Feb 18.
5
Editorial: Resistance to endocrine therapies in cancer, volume II.社论：癌症内分泌治疗耐药性，第二卷。
Front Endocrinol (Lausanne). 2024 Apr 23;15:1414392. doi: 10.3389/fendo.2024.1414392. eCollection 2024.
6
Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk.乳腺癌内分泌治疗耐药：利用雌激素受体/生长因子信号转导的相互作用
Endocr Relat Cancer. 2006 Dec;13 Suppl 1:S15-24. doi: 10.1677/erc.1.01273.
7
Enhancing Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: Cotargeting Signaling Pathways.增强激素受体阳性晚期乳腺癌的内分泌治疗：靶向信号通路。
J Natl Cancer Inst. 2015 Aug 6;107(10). doi: 10.1093/jnci/djv212. Print 2015 Oct.
8
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer.乳腺癌内分泌耐药机制及新型治疗策略
Endocr Relat Cancer. 2005 Dec;12(4):721-47. doi: 10.1677/erc.1.00857.
9
Integration of signal transduction inhibitors with endocrine therapy: an approach to overcoming hormone resistance in breast cancer.信号转导抑制剂与内分泌治疗的联合应用：一种克服乳腺癌激素抵抗的方法。
Clin Cancer Res. 2003 Jan;9(1 Pt 2):524S-32S.
10
Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer.生长因子受体与雌激素受体的相互作用作为乳腺癌中他莫昔芬耐药的一种机制
Breast. 2003 Dec;12(6):362-7. doi: 10.1016/s0960-9776(03)00137-1.
引用本文的文献
1
Overcoming drug resistance through extracellular vesicle-based drug delivery system in cancer treatment.癌症治疗中基于细胞外囊泡的药物递送系统克服耐药性
Cancer Drug Resist. 2024 Dec 12;7:50. doi: 10.20517/cdr.2024.107. eCollection 2024.
本文引用的文献
1
Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications.乳腺癌中的代谢重编程及其治疗意义。
Cells. 2019 Jan 26;8(2):89. doi: 10.3390/cells8020089.
2
Autophagy and endocrine resistance in breast cancer.自噬与乳腺癌内分泌耐药。
Expert Rev Anticancer Ther. 2011 Aug;11(8):1283-94. doi: 10.1586/era.11.111.
3
Mechanisms of endocrine resistance in breast cancer.乳腺癌内分泌耐药的机制。
Annu Rev Med. 2011;62:233-47. doi: 10.1146/annurev-med-070909-182917.
Zotero 插件